A surveillance system to monitor the incidence of diagnosed hepatitis C reinfection in New South Wales residents who have received direct acting anti-viral therapy for hepatitis C infect START DATE 15/05/2019 PROGRAM SURE CHIEF INVESTIGATOR Christine Selvey ORGANISATION AFFILIATION New South Wales Department of Health RELATED SOLUTION SURE Safely share data with SURE Conducting research in SURE Stay in touch with us Sign up to receive our newsletter Stay in touch with us Sign up to receive our newsletter. Sign up to receive our newsletter Evidence Matters, delivered monthly Notifications about Training & Events Name(Required) Email(Required) EmailThis field is for validation purposes and should be left unchanged. SHARE THIS PAGE FacebookTweetLinkedIn PRINT THIS PAGE